Abel Hall LLC’s Clover Health Investments CLOV Stock Holding History

Abel Hall LLC’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,414	Closed	-$26.8K	–	847
2025 Q4	$26.8K	Buy	+11,414	New	+$31.2K	0.01%	687

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Abel Hall LLC's CLOV Position: Q1 2026 in Review

Abel Hall LLC sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 11,414 shares — an estimated $26.8K sold.

Abel Hall LLC first reported a position in CLOV in Q4 2025 and held it in 1 quarter. The position peaked at $26.8K in Q4 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

Abel Hall LLC reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 11,414 Clover Health Investments shares in Q1 2026, an estimated $26.8K.
Abel Hall LLC first reported a position in Clover Health Investments in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Clover Health Investments position peaked at $26.8K in Q4 2025.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.